Free assessment, 100% online
Answer some questions about your health history, lifestyle, and goals via our online medical intake.
Take the assessment
Compounded semaglutide
Microdosing semaglutide activates the GLP-1 pathway at lower doses, reducing side effects and may support longevity protocols.
The exact formulation and dispensing pharmacy depend on clinical review, your state, and current fulfillment availability.
GLP-1 injections may cause nausea, diarrhea, or vomiting. To help manage symptoms while your body adjusts, eligible patients may add a fast-acting anti-nausea medication.
Answer some questions about your health history, lifestyle, and goals via our online medical intake.
Take the assessmentA licensed medical provider will review your information and determine if medication is right for you.
Find out if I am eligibleIf prescribed, your medication is cold-shipped directly to your door at no extra cost.
Get startedThere has been growing scientific data suggesting that GLP-1 agonists are beneficial for longevity via several mechanisms that are independent from weight loss.

Third Avenue Clinical Team
Board-certified physicians & researchers
Why GLP-1s
Charts and references are illustrative representations intended to communicate published research findings and the known pharmacologic properties of a medication class. They do not establish that any specific formulation or treatment program will produce identical results. Compounded medications are not evaluated by the FDA for safety, quality or efficacy.
How GLP-1 RA works
Semaglutide is a GLP-1 receptor agonist that mimics the GLP-1 hormone produced in the gut. Receptors are located in the brain, gut, heart, and pancreas, where activation supports appetite regulation, blood sugar balance, and metabolic function.
GLP-1 is a hormone your gut produces naturally, lasting only 1-2 minutes. GLP-1 receptor agonists are engineered to activate the same receptors for days instead of minutes, providing sustained appetite regulation and metabolic support.
Research suggests that low-dose semaglutide can activate longevity-relevant pathways including moderate weight loss, glycemic control, and liver health.
Side effects from semaglutide are dose-dependent. In clinical trials, dropping from 2.4 mg to 1.0 mg reduced the rate of digestive side effects by 6% (absolute reduction).
Treatment plans designed around your goals. No wait lists.
No membership fees, no hidden costs. Pay only after a doctor prescribes.
Specialist physicians licensed in your state, with unlimited messaging.
Every protocol is built by medical experts based on longevity research.
Titration matched to your goals and tolerance.
Low-dose semaglutide is an emerging therapeutic for patients who experience side effects at standard doses. Early research suggests it may preserve the same longevity-relevant mechanisms as higher doses, including glycemic control, liver health, inflammation, and oxidative stress.
Semaglutide Microdose is available in a weekly injectable form. Your provider will determine which medication and dose is appropriate for you. Always follow instructions from your doctor.
Higher doses of semaglutide are associated with more side effects. At full dose, the most common side effects are nausea, diarrhea, vomiting, constipation, abdominal pain, headache, and fatigue. Lower doses and slower titration can reduce the frequency of these side effects.
Not recommended for people with a personal or family history of medullary thyroid cancer or MEN2. Your doctor will evaluate whether Semaglutide Microdose is appropriate for you.